Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types
Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands
Pneumococcal population in the era of vaccination: changes in composition and the relation to clinical outcomes
Rijksinstituut voor Volksgezondheid
Rijksinstituut voor Volksgezondheid